“…[2][3][4] Cytarabine also exhibited remarkable synergistic effect with other anticancer drugs like Daunorubicin, Vinblastin and cis-diaminodichloroplatin (II) (CDDP). 5,6 However, the main disadvantages of antitumor therapy with Cytarabine are related to its acute and chronic toxicity to internal organs [7][8][9][10][11][12] helices. 18,19 Bicyclic pyrimidine nucleoside analogues (BCNAs) are widely known for their antiviral activity against various RNA and DNA viruses such as: VZV, 20,21 HCMV, 22,23 HCV, 24,25 HBV 26 and the vaccinia virus (VACV).…”